Seltzer H S, Allen E W, Herron A L, Brennan M T
J Clin Invest. 1967 Mar;46(3):323-35. doi: 10.1172/JCI105534.
Insulin secretory responses to paired intravenous and oral glucose loads were determined in 38 nonobese individuals classified as normal (nondiabetic) subjects, "mild" diabetics (fasting blood glucose below 105 mg per 100 ml), or "moderate" diabetics (fasting glucose below 192 mg per 100 ml). Studies were also performed in 29 obese persons who were similarly grouped. The intravenous load was given to assess the alacrity of hormonal release after glycemic stimulus, and the oral glucose to determine how the speed of initial insulinogenesis modifies the disposition of ingested carbohydrate. In the nonobese group, normal subjects responded to massive hyperglycemia after rapid injection of glucose with immediate and maximal outpouring of insulin, in contrast to a desultory insulinogenic response in patients with mild diabetes, and no initial response at all in moderate diabetics. During oral glucose tolerance tests, the much faster clearance of blood sugar in nondiabetic subjects was actually associated with lower absolute insulin output than was found in mildly diabetic patients, since the latter exhibited delayed hyperinsulinemia in concert with prolonged hyperglycemia. Moderate diabetics never showed excessive insulin release despite even greater hyperglycemia. An empirical "insulinogenic index," the ratio relating enhancement of circulating insulin to magnitude of corresponding glycemic stimulus, was used to compare the secretory capacities of respective groups. Despite the higher absolute hormonal output after oral glucose in mild diabetics, the index revealed that insulin release in normal subjects was proportionally more than twice as great. This relatively greater normal secretory response declared itself shortly after the administration of glucose by either route, and was maintained throughout both tests. In the 29 obese individuals, differences among groups were essentially the same as in persons of normal weight. Obese nondiabetics did show much larger absolute insulinogenic responses during both tests than did nonobese controls. Since corresponding glucose tolerance curves were also higher, the mean insulinogenic indexes for obese subjects were not statistically greater. Moreover, when comparable glucose curves of obese and nonobese controls
在38名非肥胖个体中测定了胰岛素对静脉注射和口服葡萄糖负荷的分泌反应,这些个体被分类为正常(非糖尿病)受试者、“轻度”糖尿病患者(空腹血糖低于每100毫升105毫克)或“中度”糖尿病患者(空腹血糖低于每100毫升192毫克)。还对29名肥胖者进行了类似分组的研究。给予静脉负荷以评估血糖刺激后激素释放的敏捷程度,给予口服葡萄糖以确定初始胰岛素生成速度如何改变摄入碳水化合物的处置。在非肥胖组中,正常受试者在快速注射葡萄糖后对大量高血糖的反应是胰岛素立即大量释放,而轻度糖尿病患者的胰岛素生成反应则断断续续,中度糖尿病患者根本没有初始反应。在口服葡萄糖耐量试验期间,非糖尿病受试者血糖清除速度快得多,但其绝对胰岛素输出量实际上低于轻度糖尿病患者,因为后者表现出高胰岛素血症延迟并伴有高血糖持续时间延长。尽管血糖更高,中度糖尿病患者从未出现过胰岛素过度释放。使用一个经验性的“胰岛素生成指数”,即循环胰岛素增加量与相应血糖刺激量的比值,来比较各组的分泌能力。尽管轻度糖尿病患者口服葡萄糖后激素绝对输出量较高,但该指数显示正常受试者的胰岛素释放量成比例地高出两倍多。这种相对较大的正常分泌反应在通过任何一种途径给予葡萄糖后不久就表现出来,并在两项试验中一直保持。在29名肥胖个体中,各组之间的差异与正常体重者基本相同。肥胖非糖尿病患者在两项试验中的绝对胰岛素生成反应确实比非肥胖对照组大得多。由于相应的葡萄糖耐量曲线也更高,肥胖受试者的平均胰岛素生成指数在统计学上并不更高。此外,当比较肥胖和非肥胖对照组的可比葡萄糖曲线时